College of American Pathologists
Printable Version

  A tidal wave of diagnostics consolidation




June 2007
Feature Story

Anne Paxton

On top of the acquisitions by GE, Siemens, and Hologic, many other mergers in the diagnostics industry have been announced in the past year and a half.

  • Inverness Medical Innovations Inc. acquired BioSite Inc. in March for $1.58 billion. BioSite makes the widely used rapid diagnostic test Triage.
  • Quest Diagnostics acquired Swedish point-of-care test developer HemoCue for $420 million.
  • Becton, Dickinson and Company bought TriPath Imaging Inc. for an estimated $350 million.
  • Beckman Coulter, which lost a recent bid for BioSite to Inverness, bought chemiluminescence developer Lumigen Inc. for $185 million. It had acquired the immunoassay provider Diagnostic Systems Laboratories Corp. in 2005.
  • Roche Diagnostics announced it is purchasing 454 Life Sciences, which specializes in gene sequencing, for $140 million. • Olympus America Inc. acquired virtual microscopy firm Bacus Laboratories and molecular diagnostics firm Gene-Ohm Sciences.
  • 3M Corp. purchased Acolyte Biomedica Ltd., a British maker of rapid microbiology products, and announced it had formed a new medical diagnostics division.
  • The German firm Carl Zeiss MicroImaging announced it will acquire the instrument systems division of cancer diagnostics developer Clarient Inc. for $12.5 million.

Anne Paxton is a writer in Seattle.


Related Links